Genetic Signatures Limited

A$0.07As of Sun 8 Nov 2026, 12:00 UTC
ASX:GSSHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (17.98%)
Div yield —
ROE (32.64%)
Diagnostics & Research
Beta (5Y) 0.63
PE TTM —
TSR TTM (76.72%)
Mkt cap A$16.13M
ROIC (18.50%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0823
15.94%
(14.49%)
Buy 5|4|1|0|1
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
25.27%
24.27%
27.78%
14.47%
Revenue$M
1.029
1.046
1.051
1.048
5.80%
3.24%
1.81%
1.88%
Peers (US$11.08M)
Cap (US$)
PE
12.89M
99.65x
12.76M
—
Capital
TTM
5Y
10Y
Leveragex
0.760
0.107
0.103
EBIT/Intx
0.697
0.323
0.328
Own earn%
(51.86)
(248.73)
(219.08)
Sh yield%
34.54
21.86
21.99
Owners
Insiders/Inst%
5.82
26.58
Short interest%
4.48
SBC / revenue%
3.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
17–22
$1 testx
—
Incr. ROIC%
65